Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
27.09.2023 - CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) - Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced ... Seite 1
/PRNewswire/ -- The urea cycle disorder treatment market size is expected to grow by USD 235.5 million from 2022 to 2027. In addition, the momentum of the...
Synlogic, Inc. (NASDAQ:SYBX – Get Free Report) saw a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 259,100 shares, a drop of 22.4% from the July 31st total of 333,700 shares. Based on an average daily volume of 203,200 shares, the short-interest ratio is […]
Chardan Capital reiterated their buy rating on shares of Synlogic (NASDAQ:SYBX – Free Report) in a research report released on Friday morning, Benzinga reports. Chardan Capital currently has a $6.00 price objective on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $5.00 target price on shares of Synlogic in […]